Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
When a telephone cable is cut across, the phone falls silent. Damaged nerves behave differently. Nerve injury causes “negative” symptoms such as hypoesthesia and numbness, the equivalent of the silent telephone. However, in addition there are often “positive” symptoms such as spontaneous pain and pain in response to weak stimuli that are normally painless. This is neuropathic pain. The pain in neuropathy results from pathophysiological changes in primary sensory neurons caused by nerve injury and disease and consequent changes in signal processing in the central nervous system (CNS) triggered by the injury. Among the most important changes in the peripheral nervous system are electrical hyperexcitability and abnormal impulse generation at ectopic pacemaker sites (“ectopic electrogenesis,” “ectopia”). Ectopia in peripheral nerves contributes to neuropathic pain in two ways: (1) it directly drives pain-signaling pathways in the CNS, and (2) it can trigger and maintain a variety of amplification processes in the CNS (“central sensitization”).
Ectopic hyperexcitability may occur in neuroma end-bulbs, regenerating or collateral sprouts, patches of demyelination, and the cell soma in the dorsal root ganglion, as well as perhaps in neighboring “uninjured” neurons. It is reflected by spontaneous firing in some neurons and abnormal responsiveness to mechanical, thermal, and chemical stimuli in many more. Neuropathic sensory symptoms also result from the distorting and amplifying mechanisms associated with ectopia. Such mechanisms include afterdischarge, extra spike formation, ephaptic crosstalk, and non-synaptic neuron-to-neuron cross-excitation. The main cellular mechanism underlying the ectopic hyperexcitability in injured afferents is remodeling of voltage-sensitive ion channels, transducer molecules, and receptors in the cell membrane. Altered expression and trafficking of specific Na + and K + channels appear to be the most important processes. The abnormal accumulation of Na + channels at ectopic pacemaker sites renders the neuronal membrane resonant and induces subthreshold voltage oscillations. This, in turn, causes the electrical hyperexcitability and ectopic spiking that drives chronic neuropathic pain. CNS changes also amplify and distort afferent signals. Central sensitization is triggered and dynamically maintained by the primary discharge of afferents, including discharge originating at ectopic pacemaker sites. However, as important as CNS changes are to the pain experience, there is little indication that the CNS becomes a primary pain generator except in the event of direct brain injury (“central pain”). Central sensitization and the resulting allodynia and hyperalgesia are dependent on peripheral input and fade rapidly when this drive is brought under control.
The ectopic pacemaker hypothesis goes a long way toward explaining the various positive clinical manifestations of neuropathy: spontaneous dysesthesias and pain, hypersensibility to applied stimuli, and sensory peculiarities unique to neuropathic pain such as electric shock–like paroxysms and hyperpathia. It also accounts for the efficacy of most therapeutic agents. Abnormal electrogenesis, in turn, appears to be a consequence of a limited number of pathophysiological processes at the cellular level. Although neuropathic pain conditions have diverse clinical features, this may reflect variations on a theme rather than fundamental differences in neural mechanisms. An underlying unity of mechanism explains why pain in diverse diagnoses responds to a distinct family of treatments with a shared mechanism of action and a shared side effect profile. Knowledge of the pathophysiological mechanisms that underlie neuropathic pain can guide the development of new treatments with improved efficacy and reduced side effects.
Injury or disease affecting peripheral nerves frequently results in the development of chronic, often intractable pain. The clinical importance of neuropathic pain syndromes ( ) and the intellectual challenge that they represent provide strong incentive for revealing the underlying mechanisms. There is general consensus today that both peripheral and central nervous system (PNS, CNS) processes play a role. The CNS changes, however, are driven largely by changes in the PNS. Thus, controlling pathophysiological change in the periphery is likely to have greater therapeutic impact than approaches that target CNS processes. PNS processes also tend to be more accessible to therapeutic intervention. The aim of this chapter is to summarize the state of knowledge on PNS pathophysiology associated with neuropathic pain, with special emphasis on processes relevant to clinical symptoms.
Chronic pain resulting from nerve injury and disease is paradoxical. Just as cutting a telephone wire leaves the line dead, cutting axons should deaden sensation. Sure enough, denervation of a body part does result in hypoesthesia or complete numbness, the hallmark “negative” symptoms of neuropathy. However, nerve pathology is also associated with “positive” symptoms and signs, including the following:
Spontaneous paresthesias, dysesthesia, and frank pain
Pain evoked by normal weight bearing, movement, and deep palpation (tender points, trigger points, and the Tinel sign)
Hypersensibility to stimuli in the partially denervated body part (allodynia and hyperalgesia)
Hyperpathia
Neuropathic pain is frequently described in terms of natural stimuli—burning, stabbing, or cramping, for example. However, these stimuli may be accompanied by peculiar sensations that are more or less unique to neuropathy, such as pins and needles, electric shock–like paroxysms, “aftersensation” (persistence of the sensation after the stimulus has ended), and “hyperpathic” phenomena such as the spread of sensation beyond the site of stimulation or pain that starts dull but with repeated stimulation “winds up” to an unbearable crescendo ( ). These peculiar sensations are sufficiently distinctive that their presence may be sufficient to diagnose a chronic pain as being neuropathic in origin ( ). Progress in animal and clinical research has advanced enough that it can now provide a reasonable framework for understanding the pain in neuropathy, including its bizarre peculiarities.
Sensation, including pain, is the domain of the nervous system. Although this may seem trivially obvious, it is sometimes forgotten that stimuli delivered to skin, muscle, bone, and viscera give rise to pain only by virtue of the nerve fibers that innervate them. Completely denervated tissue is numb. On the other hand, sensations that feel as though they originated in a particular body part can be due to impulses generated in nerves, sensory ganglia, or the CNS, even if the tissue itself is numb or completely absent. Examples are anesthesia dolorosa and phantom limb pain. In these cases the sensations are “referred to” the numb or absent body part. Understanding neuropathic pain means understanding how neuropathy affects the generation of sensory signals and their transmission to the CNS for processing. Correspondingly, when planning a treatment strategy the first question that needs to be asked is “Where are the pain-provoking impulses coming from?”
Normally, pain is felt when signals originating in thinly myelinated (Aδ) and/or unmyelinated (C) nociceptive afferents reach a conscious brain. Examples are pinprick or a stubbed toe. The pain is always evoked by stimuli; spontaneous pain is not normal. The sensation felt (pain) corresponds in location, time, and quality to the stimulus (noxious) in the expected manner. This is “normal” (or nociceptive) pain.
In addition to evoking acute nociceptive pain, burns, abrasions, chemical irritations, and infections often cause more prolonged pain, both spontaneous and evoked by stimuli. Pain in response to weak, normally innocuous stimuli is “allodynia”; exaggerated pain in response to stimuli expected to be (moderately) painful is “hyperalgesia” ( ). In the case of allodynia, at least, tenderness in the “sensitized” tissue (pain) no longer corresponds to the stimulus (non-noxious). This type of pain is usually called inflammatory pain since it is typically accompanied by an immune response and mediated by pro-inflammatory molecules. It should be noted, however, that pungent substances such as capsaicin and (non-injuring) electrical shocks can provoke pain with these characteristics even though they do not damage tissue or elicit an immune response.
Neuropathic pain, like inflammatory pain, involves pathology; it is not “normal,” and it often features sensitization and allodynia and hence mismatch between stimulus (non-noxious) and response (pain). It differs, however, in that it is caused by a lesion or disease of the somatosensory nervous system itself. This distinction is not without problems. Pain from inflammation in a major nerve trunk (“neuritis”) is generally considered neuropathic. On the other hand, even minor trauma to skin, muscle, or joint always injures the terminal part of some nerve fibers. Despite the neuropathy present, however, such pain is rarely neuropathic. The reason is that except in rare cases, the minor neural injury is not the cause of the pain. Neuropathic pain is also distinguished from inflammatory pain by the frequent presence of unique sensory features such as electric shock–like sensations and hyperpathia.
Normal (nociceptive) pain and inflammatory pain are adaptive design features of the intact pain system—an alarm bell. Neuropathic pain, in contrast, reflects faulty, maladaptive functioning of a pain system that has been damaged. Consider a defective alarm system constantly producing false alarms. All three types of pain can and often do co-exist. For example, a space-occupying tumor may simultaneously apply noxious force to otherwise healthy tissue evoking nociceptive pain, trigger an inflammatory response, and directly injure nerves. The relationships among these different pain terms are illustrated in Figure 61-1 .
Sensitization by chemical substances, inflammation, and neuropathy may result from PNS and/or CNS processes. The classic explanation of tissue hypersensibility is the “sensitized nociceptor” hypothesis ( ). According to this hypothesis, hypersensibility is due to a reduction in the threshold of nociceptive sensory endings, such as in the skin (“peripheral sensitization”). This is probably the right explanation in the case of heat allodynia. Bradykinin and many other inflammatory mediators are known to cause thermosensitive nociceptors to respond to modest warming at temperatures normally too low to evoke pain. The result is “heat allodynia.” If the threshold falls below the ambient temperature, impulse firing and burning pain will appear to be spontaneous. Likewise, sensitized nociceptors show an exaggerated response to suprathreshold heat and mechanical stimuli, including de novo responses of previously insensitive C fibers ( ). This yields “heat and mechanical hyperalgesia.” However, the sensitized nociceptor hypothesis does not explain “tactile allodynia” i.e., pain evoked by light touch. The mechanical response thresholds of Aδ and C nociceptors rarely drop into the range that evokes tactile allodynia no matter what inflammatory mediator is applied ( ; ; ; ; ; ; , ). Rather, a considerable body of evidence indicates that tenderness to touch is signaled by low-threshold Aβ touch afferents, not sensitized nociceptors.
The radical idea that pain can be signaled by non-nociceptive low-threshold afferents comes from many observations. First and foremost is response time. If sensitized C-fiber nociceptors were to blame, there ought to be a long delay between the tactile stimulus and the pain, about a second for an inflamed finger (≈1-m conduction distance at ≈1 m/sec) and longer for an inflamed toe. One could argue that the immediate response actually experienced is due to sensitized Aδ nociceptors. However, one would then expect that each touch would evoke two volleys of pain, a rapid Aδ-fiber response and then a later C-fiber response (first and second pain). Tactile allodynia is a common, almost an everyday event, and a 1-second delay between stimulus and response could not be missed. Such delays do not occur ( ). A second argument is that sensitized nociceptors show only a small reduction in the tactile response threshold. As noted above, few if any come to respond to the light brush, touch, and air puff stimuli that evoke allodynic pain. A variety of additional observations involving afferent-selective nerve block, intraneural electrical stimulation, absence of flare, and others support the conclusion that the signal that evokes tactile allodynia is carried centrally by rapidly conducting, thickly myelinated, Aβ, low-threshold mechanoreceptive touch afferents ( ).
The existence of “Aβ pain” constitutes a revolution in our understanding of both inflammatory and neuropathic pain. Indeed, since tactile allodynia is an important cause of suffering and disability in patients with neuropathic pain, pain signaled by Aβ touch afferents may be as important as pain signaled by nociceptors. However, how can Aβ fibers, which normally evoke touch, come to evoke pain? This is due largely to altered central processing of the peripheral signal, or central sensitization ( ). Central sensitization, in contrast to peripheral sensitization, is not simply a threshold-lowering process. Indeed, in tactile allodynia there is no noticeable change in the response threshold of Aβ touch-sensitive fibers to touch stimuli. Moreover, the sensation that they evoke is not strong touch. It is pain. Rather than simply amplifying, central sensitization changes the modality of the response from touch to pain. This is accompanied by a corresponding change in the cortical areas activated ( ). A large variety of electrophysiological mechanisms have been proposed to explain this transformation. Examples include activation of previously blocked N -methyl- d -aspartate (NMDA)-type glutamate receptors, imbalance in chloride ion equilibrium, loss of inhibitory interneurons, activation of glia, and altered descending control. Mechanisms of central sensitization will not be discussed here, although the concept will be referred to frequently.
Neuropathic pain can be induced by trauma, vascular and metabolic disorders, bacterial and viral infection, inflammation, autoimmune attack, genetic abnormalities, chemotherapeutic agents and other neurotoxins, burns, and a wide variety of other pathological processes that affect peripheral nerves, sensory ganglia, spinal roots, and CNS structures. The specific precipitating event appears to be less important than its common pathological effects: (1) axonopathy, ranging from deficits in axoplasmic transport to frank transection of the axon (axotomy), and (2) segmental dysmyelination or demyelination.
It is obvious how nerve damage–induced failure of signal conduction can cause hypoesthesia and numbness (negative symptoms), but why does it cause positive symptoms such as dysesthesia and pain? Not long ago the positive symptoms defied explanation. Now, we count too many potential explanations. Neuropathy triggers a large number of distinct cellular and molecular changes in the PNS and CNS. The need is to rank the importance of the numerous contenders. This challenge is illustrated by results from a relatively new technology, the expression microarray (“gene chip”).
Microarrays are devices that permit one to quantify the level of expression of large numbers of genes or even all genes simultaneously. Until their advent, molecular changes in axotomized dorsal root ganglion (DRG) cells were generally identified one at a time by using immunohistochemistry or molecular separation methods. These approaches revealed that the levels of dozens of molecules relevant to pain are affected by axotomy. That is, axotomized neurons undergo “phenotypic switching.” The peptide neurotransmitter substance P, for example, is depleted from many DRG neurons and their intraspinal terminals after nerve injury (expression of the corresponding gene is “down-regulated”). In parallel, expression of neuropeptide Y and galanin is increased (“up-regulation”; ). Interestingly, different neuron types may respond differently. For example, although the substance P level is reduced in small (nociceptive) neurons in the DRG, it is increased in large (touch-sensitive) neurons ( ). The expression and synaptic release of substance P from the central terminals of Aβ fibers secondary to phenotypic switching could itself explain how touch-sensitive afferents could come to signal pain after nerve injury ( ).
Using gene chips we now know that upward of 10% of all genes expressed in the DRG are significantly up- or down-regulated in some neuropathic pain models. The fraction is even higher if one considers only genes directly related to neuronal excitability. Levels of at least 2000 genes expressed by sensory neurons, and perhaps as many as 4000 or more, are changed by neuropathy ( ). However, this is not the end. Many genes contribute to the synthesis of more than one protein product, either through alternative splicing, by generating transcription factors, or by serving as enzymes in biosynthetic pathways. This multiplies the true molecular effects of neuropathy. Finally, beyond DRGs, massive changes also occur in the skin, nerve, spinal cord, and brain. The potential complexity is enormous.
Even though each one of the thousands of changes that constitute phenotypic switching can, in principle, be translated into a theory of neuropathic pain, it is a safe bet that not all are in fact related to pain. In addition to pain, nerve injury also triggers cell survival programs, responses to metabolic stress, regeneration, and other cellular processes. It is therefore essential to evaluate neuropathy-induced changes and identify those with functional importance for pain. Strategies for doing this will require creative thinking.
In this chapter I confront the problem of too many pain theories with a simple overriding principle. Pain perception occurs in the brain, but the precipitating injury occurs in the periphery. Since impulse discharge is the only way that pain signals can be conveyed rapidly from peripheral generators to the brain, changes that lead to abnormal electrogenesis deserve special attention. The slow signaling processes associated with axoplasmic flow also need to be considered. I place emphasis on the PNS because this is the location of the primary lesion and the primary pathophysiology. As stated, the CNS also contributes. However, as we shall see, the central changes involved in neuropathic pain are mostly triggered and maintained by abnormal input from the periphery. Thus, controlling the peripheral process can also reverse the central ones. The exception is pain caused by direct injury to the brain or spinal cord, or “central neuropathic pain.” Here, quite different processes come into play. Mechanisms of central pain will not be discussed in this chapter.
The structural changes caused by nerve injury and disease form an important backdrop for understanding neuropathic pain, but they do not in themselves explain the pain. A priori, axotomy and loss of myelin are expected to block conduction and yield hypoalgesia. Classic studies that focused on histopathology failed to reveal a consistent link between structural change and pain. They could not account for the reason why some neuropathies are painful whereas others are not ( ). The reasons are now emerging. The link is altered electrogenesis. It is not enough that neural injury has occurred. One must determine whether the injured afferent neuron has become electrically hyperexcitable.
When an axon is severed traumatically or as a consequence of disease, the proximal stump, the part still connected to the cell body, seals off and forms a terminal swelling, or “end-bulb” ( Fig. 61-2 ). It may also die back for a few millimeters. The myelin sheath near the cut end is invariably disrupted ( ). Within hours or a day or two, numerous fine processes (“sprouts”) may start to grow out from the end of the axon. Under optimal conditions, blunt nerve compression or freezing, for example, many or all of these regenerating sprouts elongate within their original endoneurial tube and re-form connections with their original peripheral targets. Excess sprouts are culled and function is restored.
In contrast, when forward growth is blocked, such as after limb amputation or when the severed nerve ends are separated by a gap, regeneration fails and end-bulbs and aborted sprouts form a tangled knot at the proximal nerve end with spread into nearby tissues. This is a “nerve-end neuroma.” Tight ligation of the end of the nerve suppresses sprouting and leaves a neuroma with end-bulbs but few sprouts ( ). Intermediate states also occur, such as when the nerve sheath (perineurium) is breached but the cut ends do not separate or when they are surgically reapproximated. Here, a fraction of fibers successfully elongate into the distal end of the nerve, although many reach inappropriate end structures. For example, skin grafts become reinnervated, with some return of sensation, but the epidermis is left with a reduced complement of sensory endings resulting in hyposensibility. Fibers that fail to regenerate become trapped in a “neuroma-in-continuity” at the injury line ( ). Pain is associated with less successful regeneration ( ).
Individual elongating sprouts may get caught up on their way to the peripheral target and form disseminated “microneuromas” scattered along the distal nerve trunk, its tributaries, and distal target tissues. Disseminated microneuromas can also form when the cell body is unable to support a long sensory axon because of metabolic disease or DRG infection (e.g., in diabetic sensory polyneuropathy or post-herpetic neuralgia). The soma may survive, but the distal axon “dies back” and leaves the epidermis partially or completely denervated and subdermal nerve branchlets awash in retracted axon end-bulbs. Hypersensitive sprouts and intradermal end-bulbs can account for the seeming paradox of spontaneous pain and allodynia in the skin coupled with axonal loss in the epidermis ( ).
In neonates, axotomy usually leads to rapid death of the cell soma. This is due to disruption in the retrograde transport of sustaining neurotrophic molecules (e.g., nerve growth factor [NGF] and glial-derived neurotrophic factor [GDNF]) normally supplied by innervated target tissues. A consequence of loss of the cell body is the loss of axons, absence of neuroma formation, and minimal neuropathic pain (e.g., phantom limb pain; ). In adults, sensory neurons are less dependent on trophic support. Few succumb to axotomy except after long intervals, but as noted, gene expression is reprogrammed and function altered.
Neuromas, sprouts, and patches of dysmyelination are structural entities. Whether they contribute to pain depends on whether their formation is accompanied by the development of electrical hyperexcitability. In classic studies, electrophysiological recordings were made from sensory axons that terminate in an experimental nerve-end neuroma, and massive spontaneous discharge of impulses was observed. The firing was generated in the neuroma and was eliminated (transiently) by resection of the neuroma and by local anesthetic block of the nerve end. Likewise, it was enhanced by mechanically probing the neuroma ( Fig. 61-3 ; also see Fig. 61-2 ; ). Similar ectopic electrogenesis (ectopia), both spontaneous and evoked by stimuli, also occurs at mid-nerve locations such as neuromas-in-continuity, disseminated microneuromas, and sites of demyelination such as experimental entrapment neuropathies ( ). Subsequent research revealed ectopic spontaneous and evoked electrogenesis at additional pacemaker locations in injured nerves: in regenerating sprouts ( ); at sites of nerve inflammation (neuritis) ( ); in experimental diabetic polyneuropathy ( ); after viral infections ( ); after vincristine, taxol, and methylmercury intoxication ( ); and in hereditary demyelinating polyneuropathies ( ). The specific agent that causes neural injury may have some effect, but not a critical one. Pathophysiological discharge can emerge no matter how axons are injured.
In all these cases the discharge is “ectopic” because it originates away from the normal location of sensory impulse generation, the peripheral sensory ending. As expected, activity generated ectopically drives spinal and higher-order neurons in the CNS in the normal way. This has been confirmed by electrical recording, imaging, and the use of activity markers ( ). Note that the terms “ectopic” and “ectopia” do not imply that the abnormal discharge necessarily arises spontaneously. Discharge evoked by the application of stimuli at locations where impulse initiation does not normally occur, at the wrist in carpal tunel syndrome, for example, is also ectopic. With one known exception, heat ( ; ), natural non-traumatic stimuli applied at a mid-nerve location do not evoke impulse discharge or refered sensation. In the presence of neuropathy, however, they frequently do. Nerve injury triggers a fundamental change in the midportion of axons that renders them locally hyperexcitable and capable of ectopic electrogenesis.
Spontaneous ectopic discharge occurs in both myelinated (A) and unmyelinated (C) fibers, although with certain differences. Activity in A fibers tends to commence earlier, is found in a higher proportion of neurons at its peak, and is characterized by higher firing rates and more bursting than is activity in C fibers ( Fig. 61-4 ). In A fibers the ectopia is usually rhythmic; that is, there is a fixed interval between subsequent impulses within a train (usually 65–35 msec, which translates to an instantaneous discharge rate of 15–30 Hz). In many fibers the impulse train is interrupted by silent pauses, which results in a bursting, on–off pattern (“interrupted autorhythmicity”; see Fig. 61-3 ). The remaining A fibers, as well as most C fibers, fire in a slow, irregular pattern (0.1–10 Hz; ). Spike patterning, particularly bursting, can have an effect on post-synaptic neurons over and above the average firing rate by virtue of temporal summation of excitatory post-synaptic potentials during bursts ( ).
Different afferent types differ in their tendency to develop spontaneous firing or to become ectopically mechanosensitive. However, it is difficult to identify in which functional types ectopia preferentially develops. The problem is that axotomy disconnects the receptor ending from the rest of the axon. Heroic efforts are required to preserve information about the original receptor type over the many hours or days that elapse before ectopic firing begins. Partial information has been obtained from conduction velocity, from the ability to follow tetanic stimuli (the “marking method”), by comparing recordings from dorsal versus ventral roots, and from examination of cutaneous nerves versus nerves serving muscle, viscera, and other tissues. Injured sensory axons are much more likely than injured motor axons to generate spontaneous ectopic activity. Aβ and Aδ afferents are represented roughly in proportion to their numbers in the nerve. Interestingly, although injured cutaneous afferents frequently show ectopic mechanosensitivity without spontaneous firing, muscle afferents are more likely to fire spontaneously, at least after distal axotomy ( ). Perhaps this is because muscle nerves normally contain many tonic and slowly adapting afferent fiber types (muscle spindle afferents, proprioceptors). Neuroma end-bulbs and sprouts tend to develop the same sensitivities that they had before injury, presumably because of fiber type–specific gene expression at the level of the cell soma ( ).
Since neuromas are an important source of painful ectopia, it seems logical that surgical resection or neurolysis should bring relief. Unfortunately, shortly after neuroma resection the same pathophysiological processes that caused pacemaker activity in the first place are re-engaged at the freshly cut nerve end, perhaps even in intensified form as a result of priming. Surgical mobilization of a neuroma to a site with a reduced likelihood of mechanical compression, however, may provide long-term relief in cases in which mechanosensitivity rather than spontaneous firing is the main problem (Campbell 2007). Different nerves behave differently. An incision for thoracotomy, for example, which frequently damages intercostal nerves, is much more likely than a comparable incision in the abdomen to be followed by neuropathic scar pain. For reasons that are not entirely clear, destruction of the tooth pulp in root canal treatment or tooth extraction does not commonly induce a painful neuroma. The same seems to be true of the intrinsic innervation of long bones. In hip replacement surgery, the femur is cut across and a prosthetic joint and bone cement are introduced into the bone marrow chamber. Yet despite the massive destruction of intrinsic bone afferent axons, the development of chronic neuropathic pain is infrequent. This suggests that pain relief might be achieved in patients with osteoarthritis by intrinsic denervation of the epiphyseal end of the bone, just as in dental root canal treatment ( ).
Cutting the spinal nerve just peripheral to the DRG evokes ectopia in the dorsal root, altered dermatomal borders, and cutaneous hypersensibility. This does not occur when the same axons are cut just central to the DRG, in the dorsal root ( ). The authors concluded that the DRG is the source of the spontaneous firing, although they did not adequately rule out the most obvious alternative source, the spinal nerve neuroma. It later became clear that the DRG is indeed a major source, along with the neuroma ( ). In fact, head-to-head comparisons in both the sciatic neuroma model and the spinal nerve ligation model in rats have shown that about 75% of the overall spontaneous discharge generated in the injured nerve originates in the DRG and 25% in the neuroma ( ).
In addition to the presence of spontaneous firing, activity in DRG neurons is initiated or exacerbated by the same physical and chemical stimuli that drive ectopia in neuromas. Despite the fact that the DRG is protected from direct stimulation by the rigid walls of its bony foramen and that DRG neurons have (almost) no synaptic input, there are nonetheless many factors capable of producing depolarization. For example, DRG neurons can be excited by mechanical stimulation during movement or straight-leg raising (which pulls on the sciatic nerve), by sympathetic efferent activity, by excitatory substances released within the ganglion as a result of activity in neighboring neurons (chemical “cross-excitation”), by agents in the systemic circulation, and by changes in temperature. Each of these factors will be considered below in more detail.
There is specific evidence that ectopia originating in DRG neurons contributes to neuropathic pain. In animal models, increasing or decreasing spontaneous ectopia by delivery of pharmacological agents direct to the ganglion has corresponding effects on pain behavior ( ). The mechanosensitivity of the DRG appears to be particularly significant because of its major role in movement-evoked pain in disorders of the vertebral column. used a local anesthetic technique to expose the spinal nerves and DRGs in patients with sciatica that permitted them to talk to the patients during the procedure. Mechanical stimulation of the spinal nerve and DRG capsule consistently provoked the patients’ characteristic shooting sciatica pain, whereas probing the local fascia, annulus fibrosus, periosteum, and other tissues produced only local sensations. The nerve root and DRG are subjected to tensile stress during everyday movement and during maneuvers such as straight-leg raising ( ). Normally, this does not evoke any sensation. However, if ectopic mechanosensitivity has developed as a result of neuropathy, radiculopathy, or ganglionopathy, these forces are translated into ectopic impulse discharge and pain ( ).
Interestingly, a small number of DRG neurons fire spontaneously even in the absence of nerve injury ( ). This activity might contribute to the background sense of body schema. For example, when all nerves to a limb are blocked in healthy subjects, most feel a non-painful “normal phantom” rather than absence of the limb ( ). Likewise, dental anesthesia is followed by the sensation of a swollen lip, not a hole in the face. These phantom sensations may be due to background DRG discharge. Given that ectopic electrogenesis in the DRG is a significant factor in the etiology of neuropathic pain, it may also be an effective target for therapeutic intervention. This includes cases of nerve trauma, as well as conditions such as post-herpetic neuralgia and a herniated intervertebral disc, in which the DRG itself is directly affected by the disease process. The implications of the DRG as a therapeutic target for pain control in patients with neuropathic pain have not yet been widely realized.
Within nerves and in skin and other tissues, sensory fibers tend to intermingle such that any given tissue volume is innervated by afferents from more than one nerve branch and more than one DRG. For this reason, when a fraction of the axons in a nerve are injured and undergoing anterograde (wallerian) degeneration, the residual “uninjured” axons in the nerve and its target tissues are exposed to degeneration products. In addition, wallerian degeneration evokes an inflammatory response and the appearance of immune cells and diffusible pro-inflammatory mediators in the nerve and target tissue. These mediators, which include interleukin-1β (IL-1β), IL-6, tumor necrosis factor-α (TNF-α), and NGF, are released by fibroblasts, mast cells, endothelial cells, Schwann cells, locally activated or invasive immune cells, and in the skin, keratinocytes ( ). It has been reported that such “uninjured” afferents begin to fire spontaneously, albeit at extremely low discharge rates, often less than 1 spike/min ( ). The location of the electrogenesis has not been determined; if it comes from sensitized sensory endings, it would not be ectopic. However, wherever these impulses originate, they add to the overall ectopic barrage that drives spontaneous pain. This spontaneous activity may make a special contribution to the spontaneous burning pain that is so common in neuropathy. It might also play a role in tactile allodynia by contributing to the maintenance of central sensitization.
Beyond their potential for contributing to spontaneous ectopia, “uninjured” afferents also emit “collateral sprouts.” This is probably a result of elevated tissue levels of NGF ( ). Collateral sprouting, which also occurs in humans ( ), is easiest to detect at innervation boundaries. Here, C fibers sprout and invade neighboring denervated territory, thereby restoring nociceptive sensation. But, sprouting also occurs at the center of partially denervated tissue ( Fig. 61-5 ). Residual sensory endings and collateral sprouts, all bathed in inflammatory mediators, have long been suspected as being contributors to allodynia and hyperalgesia. This is uncertain, however, because collateral sprouts do not respond readily to weak tactile stimuli ( ; but see ). Sprouts do show enhanced sensitivity to circulating and applied adrenaline and to sympathetic efferent activity ( ; ; ). This may drive activity, and consequent pain, that appears to be spontaneous. Topically applied lidocaine and adrenergic blockers probably provide pain relief by suppressing the spontaneous drive originating in the skin and the central sensitization that it maintains.
The method of percutaneous microneurography has extended observations on ectopia to awake humans, including those with neuropathic pain. It remains a research rather than a diagnostic tool, however, because of its technical difficulty and intrinsic risk. Practitioners have been justifiably reluctant to insert microelectrodes into already problematic nerves. Nonetheless, enough studies have appeared to make it clear that ectopic hyperexcitability occurs in patients as in nerve-injured animals and that it is a fundamental contributor to many clinical neuropathic pain conditions.
Not long after the first observations in animals, carried out a pioneering study in which they documented ongoing firing in the peroneal nerve in a lower extremity amputee who had ongoing phantom foot pain. Percussion of the neuroma evoked stabbing pain (the Tinel sign) and an intense burst of spike activity. The evoked bursts and the evoked pain were eliminated by local anesthetic block of the neuroma. Interestingly, however, much of the ongoing discharge persisted. The DRG is the most likely source of this persistent activity, but direct evidence of this in humans is still lacking. Subsequent microneurographic studies documented a direct relationship between ectopia and pain in a variety of other neuropathic conditions (e.g., ). For example, painful dysesthesia triggered by straight-leg lifting in a patient with radiculopathy (Lasegue’s sign) was accompanied by evoked ectopic bursts recorded in the sural nerve. The ectopic source was the injured spinal root or DRG ( ).
More recent studies have used the “marking method” to resolve activity in individual C fibers. The results provide evidence that the ongoing, often burning pain characteristic of many peripheral neuropathies is due to spontaneous discharge in C-fiber nociceptors ( ). Multiplet and burst firing, afterdischarge, and other interesting peculiarities of ectopia in animal models (below) have also been seen in patients, thus further strengthening the clinical relevance of the experimental models ( ). Other lines of evidence support these electrophysiological data. For example, pain is evoked by the application of substances known from animal preparations to excite ectopic pacemaker sites, including K + channel blockers and adrenergic agonists ( ). Likewise, blockers of ectopia such as local, regional, and systemic anesthetics suppress neuropathic pain ( ). Even the most severe pain, such as occurs in complex regional pain syndrome (CRPS), is reliably stopped by peripheral nerve or brachial plexus block, thereby permitting physiotherapy, albeit only for the duration of the block.
The foregoing observations leave little doubt that spontaneous ectopic discharge is a primary driver of spontaneous pain in humans. Spontaneous ectopia also occurs in neuropathy models in animals. Although this implies that the animals also experience spontaneous pain, proving it is not trivial. This issue is important because animal models are essential for screening novel analgesic drugs. This topic is discussed in more detail in Chapter 62 .
Spontaneously emitted behaviors such as vocalization, abnormal posture and gait, and unprovoked paw lifting occurs in neuropathy models and have been put forward as potential markers of spontaneous pain. However, follow-up study has failed to provide convincing support for this conjecture ( , Urban et al 2011). Instinctive behavioral biomarkers of spontaneous pain may not even exist in prey species such as mice and rats since they would signal vulnerability to predators and natural selection is likely to have excluded them. Convincing evidence for spontaneous pain is available from a conditioning paradigm in which animals were trained to show place preference for a chamber in which they were provided with analgesia ( ).
Autotomy behavior in the neuroma model provides another option ( ). This behavior has been validated as a biomarker of spontaneous neuropathic pain (anesthesia dolorosa) via a number of approaches ( ). For example, it is reduced by appropriate drugs, it is associated with prominent ectopia, augmenting the ectopia augments the autotomy, and suppressing it suppresses autotomy ( ). Recently, it has been shown that a gene variant that predisposes to autotomy in rodents is associated with neuropathic pain in humans ( ). Two other end points proposed recently also offer some hope: the coding of facial expressions in mice ( ) and a new procedure for tracking ultrasonic calls ( ).
Exploring the surface of an injured nerve with a fine probe reveals clusters of tiny mechanosensitive “hot spots.” They do not occur in normal nerves. Such probing excites silent axons and also accelerates discharge in already active ones ( Fig. 61-2 A and B). Spontaneous and evoked discharges almost certainly arise from the same cellular locus and pacemaker process ( ). Mechanosensitivity underlies the Tinel sign, the often stabbing or electric shock–like dysesthesia evoked by percussion of neuromas, along nerves in painful diabetic neuropathy, and in carpal tunnel syndrome, and it is responsible for the shooting leg pain in sciatica ( ). Like normal mechanosensitive endings, hot spots typically respond either with a short spike burst at the onset and/or release of a stimulus or with sustained firing for the duration of application of the force (rapid and slow adaptation). Interestingly, however, in some hot spots firing persists beyond the end of the stimulus (“mechanical afterdischarge,” Fig. 61-6 A). In effect, the brief stimulus triggers a period of spontaneous firing. This clearly abnormal pattern accounts for the frequent persistence of evoked sensation in neuropathy ( ). Locations where nerves run adjacent to tendons and bone (e.g., the carpal tunnel) or where small nerve branches cross tough fascial planes are particularly at risk for sustaining focal trauma and developing ectopic mechanosensitivity. Pain evoked at such trigger points by local palpation, weight bearing, and untoward movements may represent a neuropathic contribution to chronic musculoskeletal pain, perhaps including fibromyalgia.
Tactile allodynia, unlike hyperalgesia and tender points, is probably not a result of excessive mechanosensitivity of nociceptive sensory endings for reasons noted above (under Sensitization ). Even though tender collateral sprouts and intradermal disseminated microneuromas may well contribute, the major cause of tactile allodynia is thought to be spike activity in Aβ touch afferents processed by sensitized spinal cord circuitry. Here too, however, spontaneous ectopia in the periphery plays a crucial role: it induces and maintains the central sensitization. Thus, tactile allodynia results from pathophysiology in the PNS and in the CNS. Note that the sensory effect of spontaneous ectopia in Aβ fibers is also exacerbated by central sensitization, thereby adding to the spontaneous pain. Finally, central sensitization may amplify the sensory consequences of spontaneous and evoked activity in at least some types of nociceptors ( ).
In Figure 61-7 the sequence of events believed to underlie the tactile allodynia in neuropathy is illustrated by using the spinal nerve ligation model of neuropathic pain ( ). In this model the L5 (or L5–6) spinal nerve is cut; about half the afferents in the sciatic nerve are severed and the hindpaw is partially denervated. Cutting the nerve creates two permanent sources of spontaneous ectopic activity, the L5 spinal nerve-end neuroma and the L5 DRG. “Uninjured” nociceptors in the L4 segment may also contribute. This activity drives central pain pathways and also triggers central sensitization, hence augmenting spontaneous pain and inducing allodynia.
Corresponding observations have been made in patients. For example, observed that when a focal source of ectopia from an old scar was identified and blocked with local anesthetic, not only was the focal pain temporarily eliminated but also the widespread allodynia that the patient suffered. The same principle is also relevant to conditions such as migraine and visceral and musculoskeletal pain ( ). The focal impulse source dynamically maintains central sensitization. Remove it and hypersensibility fades, usually within minutes or at most a few hours.
Cold intolerance and cold allodynia are common symptoms in neuropathy; people who live in cold climates suffer in particular during the winter ( ). On the other hand, in some conditions, notably CRPS, patients may obtain relief by wrapping the painful limb in a cold, wet towel. This difference might reflect which primary afferents are involved ( ). Ectopic activity in C fibers tends to be excited by cooling and suppressed by warming. Collateral sprouts (which derive mostly from C fibers) and many intradermal disseminated microneuroma endings are therefore expected to be hypersensitive to cold and to provoke pain when the skin is cooled. In contrast, ectopia in A fibers is enhanced by warming, whereas cooling suppresses it. If the pain in CRPS were primarily due to Aβ fibers, this could explain why cooling provides some relief in this condition. As discussed below, the abnormal sensitivity of injured axons reflects altered regulation and trafficking of ion channels and receptors, including thermoresponsive transient receptor potential (TRP) channels. This varies with fiber type ( ).
In addition to temperature, metabolic stress and a wide array of chemical factors can also depolarize sensory neurons and directly excite discharge at ectopic pacemaker sites in neuropathy. All these factors can also sensitize pacemaker sites and make them hyper-responsive to mechanical and other stimuli. Examples include tissue ischemia and hypoxia, changes in blood gases, elevated blood glucose, altered ion concentrations, and numerous endogenous neuroactive substances, including catecholamines, adenosine triphosphate (ATP), nitric oxide, peptides, cytokines, small lipids, neurotrophins, histamine, bradykinin, prostaglandins, TNF-α, and many other pro-inflammatory mediators ( ). New mediators continue to appear regularly, which suggests that the current inventory is far from complete. The chemical milieu of afferent neurons is a major factor in ectopia and neuropathic pain, but only if ectopic pacemaker capability has developed first.
In Guillain-Barré syndrome (GBS) and related inflammatory polyneuropathies, nerves suffer widespread myelin destruction and axonopathy as a result of autoimmune attack. This causes paralysis and sensory loss. However, as in other forms of neuropathy, these negative symptoms are often accompanied by dysesthesias and ongoing pain ( ). Membrane remodeling and pain behavior have been documented in the animal model of GBS (experimental allergic neuritis), and ectopic hyperexcitability is probably present in this model ( ). There is direct electrophysiological evidence that ectopic hyperexcitability occurs at sites of focal nerve inflammation. In the chronic constriction injury model of neuropathic pain, for example, chromic gut ligatures are applied loosely to the sciatic nerve. This causes local inflammation and nerve swelling, which partially strangles the nerve ( ). Variants of this model include focal constriction of trigeminal nerve branches and compression of dorsal root and trigeminal ganglia ( ). Such injury causes frank destruction of many axons, focal demyelination of others, and the release of inflammatory mediators.
Peripheral nerve injury also triggers an inflammatory reaction in associated ganglia, including activation of intrinsic glial cells and attraction of invasive immune cells. An inflammatory milieu contributes to the development of ectopic firing at both the nerve injury site and the ganglia, with consequent spontaneous pain and hypersensibility ( ). The animal constriction and compression models emulate the many clinical conditions that feature focal neuropathy exacerbated by inflammation. Among these are carpal tunnel syndrome, disc herniation with sciatica, and solid tumors that press on nerves. Indeed, a contribution of inflammation in conditions involving neural trauma may be the rule rather than the exception.
There is also tentative evidence that inflammatory mediators might be able to act on mid-nerve fibers directly without concurrent (structural) neuropathy. Specifically, it has been reported that when TNF-α or complete Freund’s adjuvant is applied to the surface of healthy nerves or DRGs, a focus of spontaneous firing and mechanosensitivity may emerge rapidly ( ). By inference, in systemic and focal inflammatory and toxic neuropathies in which there is minimal concurrent nerve trauma, widespread pain might result from the direct action of inflammatory mediators on midaxon and intraganglionic receptors.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here